PepGen Inc. (Nasdaq: PEPG), a biotechnology company specializing in genetic therapies, received a clinical hold notice from the U.S. Food and Drug Administration (FDA) for their Investigational New Drug Application (IND) related to a Phase 1 study of PGN-EDODM1 in patients with Myotonic Dystrophy Type 1 (DM1), a complex disorder that impacts various systems within the body, including skeletal and smooth muscle, as well as the eye, heart, endocrine system, and central nervous system. 

The FDA intends to provide an official clinical hold letter within 30 days, stating the reasons behind the decision. 

Following this announcement, $PEPG is trading at $12.88, experiencing a decline of $2.90 or 18.38% in after-hours trading.

LL Flooring Holdings, Inc. (NYSE: LL), a company engaged in the flooring business, confirmed the receipt of an unsolicited proposal from Cabinets To Go, LLC, a subsidiary of F9 Brands, Inc. The proposal suggests the acquisition of all outstanding shares of LL Flooring at a price of $5.76 per share in cash. 

LL Flooring's Board of Directors, in accordance with its fiduciary duties, will thoroughly review and consider the proposal with the assistance of financial and legal advisors. The decision on the course of action will be made in the best interests of the company and its shareholders. 

$LL is trading at $4.97, up $0.83 or 20.05% in after-hours trading, following this announcement, 

JOYY Inc. (Nasdaq: YY), a company involved in live streaming and social media platforms, reported adjusted income per ADS for the first quarter of 2023 of $0.64, surpassing the consensus estimate of $0.34. 

Currently, $YY is trading at $27.49, experiencing an increase of $0.58 or 2.16% in after-hours.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)